Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer

被引:4
|
作者
Janinis, J [1 ]
Panagos, G [1 ]
机构
[1] St Anargiri Canc Ctr, Athens, Greece
关键词
D O I
10.1200/JCO.2000.18.6.1393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1393 / 1394
页数:2
相关论文
共 50 条
  • [41] CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY 5-FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER
    Lee, Y. J.
    Lee, C. G.
    Hong, S. J.
    Kim, Y. T.
    Kim, J. H.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 222 - 222
  • [42] Combination of Taxanes, Cisplatin and Fluorouracil as Induction Chemotherapy for Locally Advanced Head and Neck Cancer: A Meta-Analysis
    Qin, Hao
    Luo, Jie
    Zhu, Yuan-Ping
    Xie, Hai-Li
    Yang, Wei-Qiang
    Lei, Wen-Bin
    [J]. PLOS ONE, 2012, 7 (12):
  • [43] Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
    Hitt, R
    López-Pousa, A
    Martínez-Trufero, J
    Escrig, V
    Carles, J
    Rizo, A
    Isla, D
    Vega, ME
    Martí, JL
    Lobo, F
    Pastor, P
    Valentí, V
    Belón, J
    Sánchez, MA
    Chaib, C
    Pallarés, C
    Antón, A
    Cervantes, A
    Paz-Ares, L
    Cortés-Funes, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8636 - 8645
  • [44] Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication
    Yanlei Ma
    Huanlong Qin
    Qi Zheng
    Yu Wang
    Zhiguo Wang
    Zhe Yang
    [J]. Medical Oncology, 2010, 27 : 1089 - 1095
  • [45] Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication
    Ma, Yanlei
    Qin, Huanlong
    Zheng, Qi
    Wang, Yu
    Wang, Zhiguo
    Yang, Zhe
    [J]. MEDICAL ONCOLOGY, 2010, 27 (04) : 1089 - 1095
  • [46] Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: A phase I/II trial
    Colevas, AD
    Busse, PM
    Norris, CM
    Fried, M
    Tishler, RB
    Poulin, M
    Fabian, RL
    Fitzgerald, TJ
    Dreyfuss, A
    Peters, ES
    Adak, S
    Costello, R
    Barton, JJ
    Posner, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1331 - 1339
  • [47] Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    de Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A. K.
    Elsaesser, W.
    Kainz, H.
    Riedl, R.
    Kapp, K.
    Kopp, M.
    Kornek, G.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 273 - 273
  • [48] INDUCTION CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND 5-FLUOROURACIL FOLLOWED BY RADIOTHERAPY WITH CETUXIMAB FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Keil, F.
    Selzer, E.
    Berghold, A.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Reinisch, S.
    Anderhuber, W.
    Burian, M.
    Kornek, G. V.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 340 - 341
  • [49] Nimotuzumab plus chemotherapy with docetaxel, cisplatin, 5-fluorouracil for locally advanced head and neck squamous cell carcinoma: A clinical study
    Wang, Xing
    Gu, Jianmin
    Shao, Cuiling
    Han, Kun
    Meng, Jian
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (02) : 312 - 316
  • [50] Induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil followed by radiotherapy with Cetuximab for locally advanced squamous cell carcinoma of the head and neck
    Keil, F.
    Selzer, E.
    Berghold, A.
    Reinisch, S.
    Kapp, K.
    De Vries, A.
    Greil, R.
    Bachtiary, B.
    Tinchon, C.
    Anderhuber, W.
    Burian, M.
    Kasparek, A-K
    Elsaesser, W.
    Kainz, H.
    Kopp, M.
    Kornek, G.
    [J]. ONKOLOGIE, 2012, 35 : 194 - 194